← Back to All Filings

IDEXX Director Awarded $24.5k in Deferred Stock Units (IDXX)

Low SignificanceNovember 3, 2025 at 5:01:38 PM EST

IDEXX LABORATORIES INC /DE

$IDXX4CIK: 0000874716

Subscribe to track IDXX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

IDEXX Director Awarded $24.5k in Stock (IDXX)

Company: IDEXX LABORATORIES INC /DE (IDXX) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: HOOLEY JOSEPH L Title: N/A | Relationship: Director

Transaction: • Type: Grant • Shares: 39 • Price: $628.54 • Value: $24,513 • Owned After: 39

Key Insight: A routine grant of deferred stock units to a director as part of their compensation plan, representing a negligible portion of the company's market cap.

Market Context: The transaction value is insignificant compared to IDEXX's $50.36 billion market capitalization.

Comprehensive Analysis

SEC Filing Analysis: IDEXX LABORATORIES INC /DE (IDXX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received a routine, non-discretionary award of deferred stock units as part of a compensation plan.
  • Market Impact: Negligible. The transaction is too small to have any market impact.

Company Information

FieldValue
CompanyIDEXX LABORATORIES INC /DE
Ticker SymbolIDXX
CIK0000874716
IndustryIn Vitro & In Vivo Diagnostic Substances

Insider Information

FieldValue
NameHOOLEY JOSEPH L
CIK0001123847
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-30
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved39
Price Per Share$628.54
Total Value$24,513.06
Shares Owned After39
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$24,513.06
% of Market Cap0.00005%
Shares Transacted39
% of Shares Outstanding0.00005%
Post-Transaction Ownership39 shares (0.00005% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of ~$24.5k is insignificant for a large-cap company with a market capitalization of $50.36 billion.
  • Ownership Concentration: The director's holding of 39 shares is a negligible stake in the company.
  • Dilution Impact: The issuance of 39 shares has no meaningful dilutive effect on the 80 million shares outstanding.
  • Transaction Significance: The transaction is a routine compensation grant, not an open-market trade, and its size is far below any threshold of significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a non-discretionary award as part of a director's compensation plan, not an investment decision based on market sentiment. The size is immaterial.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. This type of filing is routine and does not signal any particular insider sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The shares represent deferred stock units acquired under the company's Director Deferred Compensation Plan. The units vest immediately and are payable in common stock upon the director's departure from the board.
Topics:#SECFiling#InsiderTrading#IDXX#IDEXX#Form4#StockGrant#DirectorCompensation#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.